<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02980133</url>
  </required_header>
  <id_info>
    <org_study_id>FSS-AS-30003</org_study_id>
    <nct_id>NCT02980133</nct_id>
  </id_info>
  <brief_title>Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler</brief_title>
  <official_title>A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients Aged 4 Through 11 Years With Persistent Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Teva Branded Pharmaceutical Products, R&amp;D Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Teva Pharmaceutical Industries</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate the safety and efficacy of Fluticasone Propionate and Fluticasone
      propionate Salmeterol in pediatric patients with a documented history of persistent asthma.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 16, 2016</start_date>
  <completion_date type="Anticipated">October 18, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 18, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>For Fp MDPI versus placebo: the change from baseline in weekly average of the percent predicted trough morning forced expiratory volume in 1 second (FEV1) at week 12</measure>
    <time_frame>Baseline - Week 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>For FS MDPI versus Fp MDPI: the change from baseline in 1-hour postdose percent predicted morning FEV1 at week 12</measure>
    <time_frame>Baseline - Week 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the weekly average of daily trough morning (predose and pre-rescue bronchodilator) PEF over the 12-week treatment period</measure>
    <time_frame>Baseline - Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the weekly average of total daily (24-hour) use of albuterol/salbutamol inhalation aerosol (number of inhalations) over weeks 1 through 12</measure>
    <time_frame>Week 1 - Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the weekly average of the total daily asthma symptom score (defined as the average of the daytime and nighttime scores) over weeks 1 through 12</measure>
    <time_frame>Week 1 - Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in asthma control (measured by Childhood Asthma Control Test [C-ACT]) over the 12-week treatment period</measure>
    <time_frame>Week 1 - Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first onset of effect defined as the first decrease from baseline in daily rescue medication use</measure>
    <time_frame>Baseline - Week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients discontinued from IMP for asthma exacerbation during the 12-week treatment period</measure>
    <time_frame>Week 1 - Week 12</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">508</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Treatment group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fp MDPI- Dose Regimen 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fp MDPI- Dose Regimen 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FS MDPI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group D</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fp MDPI</intervention_name>
    <arm_group_label>Treatment group A</arm_group_label>
    <arm_group_label>Treatment Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>FS MDPI</intervention_name>
    <arm_group_label>Treatment Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Treatment Group D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has a diagnosis of asthma as defined by the NIH

          -  The patient has persistent asthma with a FEV1 ≥50% and ≤90% of the value predicted for
             age, height, sex, and race at the screening visit (SV).

          -  The patient's persistent asthma is stable and is currently being treated with stable
             asthma therapy for at least 30 days before the SV.

          -  The patient (with assistance from parents/legal guardians/caregivers, as needed) is
             able to perform technically acceptable lung function assessments by handheld device

          -  The patient (with assistance from parents/legal guardians/caregivers, as needed) is
             able to use an MDI device and an MDPI device.

          -  All patients must be able to replace their current SABA with albuterol/salbutamol HFA
             MDI inhalation aerosol at the SV for use as needed for the duration of the study

               -  Additional criteria apply, please contact the investigator for more information

        Exclusion Criteria:

          -  The patient has a history of life-threatening asthma exacerbation that is defined for
             this protocol as an asthma episode that required intubation and/or was associated with
             hypercapnia, respiratory arrest, or hypoxic seizures.

          -  The patient is pregnant or lactating or plans to become pregnant during the study
             period or within 30 days after the patient's last study-related visit.

          -  The patient has a known hypersensitivity to any corticosteroid, salmeterol, or any of
             the excipients in the IMP or rescue medication formulation (ie, lactose).

          -  The patient has been treated with any known strong cytochrome P450 (CYP) 3A4
             inhibitors (eg, ketoconazole, ritonavir, clarithromycin) within 30 days before the SV
             or plans to be treated with any strong CYP3A4 inhibitor during the study.

          -  The patient currently smokes or has a smoking history. The patient must not have used
             tobacco products within the past year (eg, cigarettes, cigars, chewing tobacco, or
             pipe tobacco).

          -  The patient has had an asthma exacerbation requiring systemic corticosteroids within
             30 days before the SV or has had any hospitalization for asthma within 2 months before
             the SV.

          -  The patient has used immunosuppressive medications within 30 days before the screening
             visit.

          -  The patient has untreated oral candidiasis at the SV. Patients with clinical visual
             evidence of oral candidiasis who agree to receive treatment and comply with
             appropriate medical monitoring may enter the run-in period.

          -  The patient has a history of a positive test for human immunodeficiency virus, active
             hepatitis B virus, or hepatitis C infection.

          -  The patient is an immediate relative of an employee of the clinical investigational
             center.

          -  A member of the patient's household is participating in the study at the same time

          -  Vulnerable patients (ie, people kept in detention) are excluded from participation.

               -  Additional criteria apply, please contact the investigator for more information
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teva Medical Expert, MD</last_name>
    <role>Study Director</role>
    <affiliation>TEVA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Teva U.S. Medical Information</last_name>
    <phone>1-888-483-8279</phone>
    <email>USMedInfo@tevapharm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Teva Investigational Site 13881</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>205-871-9661</phone>
      <email>miskora@alabamaallergy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13883</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>501-224-1156</phone>
      <email>ksitz@littlerockallergy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13906</name>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>661-864-7710</phone>
      <email>drttanus@aol.com;drttanus@aim.com; kris4angelz@aol.com;kern4research@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 14615</name>
      <address>
        <city>Corona</city>
        <state>California</state>
        <zip>92883</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>951-314-7818</phone>
      <email>drdsylva.ctoc@gmail.com; irgtrial@sbcglobal.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13892</name>
      <address>
        <city>Downey</city>
        <state>California</state>
        <zip>90241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>562-904-2123</phone>
      <email>mgcruzmd@yahoo.com; premierhealthrc@yahoo.com; mgcruzmd@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13877</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92648</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>714-477-8001</phone>
      <email>rachel.zabaneh@hoag.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 14668</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>714-656-8909</phone>
      <email>drkkim@arkclinicalresearch.com;drkkim@wcctrials.com; drkkim@wcct.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13914</name>
      <address>
        <city>Napa</city>
        <state>California</state>
        <zip>94558</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>707-258-8147</phone>
      <email>lposnermd@northbayallergy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13918</name>
      <address>
        <city>Paramount</city>
        <state>California</state>
        <zip>90723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>562-633-5101</phone>
      <email>clinresch@aol.com; ideleonmd@sbcglobal.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 14618</name>
      <address>
        <city>Rolling Hills Estates</city>
        <state>California</state>
        <zip>90274</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13912</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13847</name>
      <address>
        <city>Stockton</city>
        <state>California</state>
        <zip>95207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>209-951-6741</phone>
      <email>docbensch4@aol.com; docbensch@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13848</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+1-949-347-8700 (113)</phone>
      <email>weberger@uci.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13856</name>
      <address>
        <city>Centennial</city>
        <state>Colorado</state>
        <zip>80112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>720-858-7510</phone>
      <email>su.gogate@coloradoallergy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13910</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>719-473-8330</phone>
      <email>rknowles@aacos.com;dsoteres@aacos.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13868</name>
      <address>
        <city>Longmont</city>
        <state>Colorado</state>
        <zip>80501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>720-929-8300</phone>
      <email>melamedi@immunoe.com; imelamed@clin-edge.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13909</name>
      <address>
        <city>Homestead</city>
        <state>Florida</state>
        <zip>33030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>786-600-0012</phone>
      <email>mariadelgadomd@homesteadmedicalclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13872</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-249-1183</phone>
      <email>serman.ojeda@medicalinvestigations.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13907</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-470-8345</phone>
      <email>yamilcanaan@jesscanmedicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13893</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33142</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>786-212-4187</phone>
      <email>armandoacevedoresearch@gmail.com;acevedoresearch@gmail.com;blakefernandezresearch@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13886</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-261-0057</phone>
      <email>yvillaman.bescosme.bpg@gmail.com; yvillamanmd@dbcresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13899</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33175</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-220-6917</phone>
      <email>hbrito@healthylife-research.com;hildambrito12260@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13864</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-931-7583</phone>
      <email>jjlandman@florida-allergy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13880</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-273-2988</phone>
      <email>research@florida-allergy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13870</name>
      <address>
        <city>Mismi Lakes</city>
        <state>Florida</state>
        <zip>33014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13876</name>
      <address>
        <city>Palmetto Bay</city>
        <state>Florida</state>
        <zip>33157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>786-339-8454</phone>
      <email>piniella@homesteadresearch.com;cgallergy@gmail.com; carlos@aktamedika.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13844</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32789</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>407-898-2767</phone>
      <email>akin@oppsa.com ; ajayi@ajayihealthcare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13866</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>678-971-5005</phone>
      <email>drmmaloney@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13858</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31406</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>912-356-3619</phone>
      <email>bgoodman@coastalallergy.net; goodman_b@mercer.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13903</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83402</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>410-933-9407</phone>
      <email>msinglamd@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13882</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>309-452-0995</phone>
      <email>drsiri@asthma2.com; vanessaprice@asthma2.com;research@asthma2.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13887</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>913-345-2383</phone>
      <email>jeff.wald@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13851</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>270-684-6144</phone>
      <email>stant@cloremd.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13849</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>402-592-2055</phone>
      <email>gdbrooks@asthmaandallergycenter.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13865</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>660-747-2397</phone>
      <email>lplandwehr@socket.net; llandwehr@ozark.aero</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13885</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>573-442-3070</phone>
      <email>clinresozcol@centrytel.net; crozarks@fidnet.com;clinresozcolstudy@centurytel.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13891</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>406-549-1124</phone>
      <email>cthornblade@montanamedicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13897</name>
      <address>
        <city>Ocean City</city>
        <state>New Jersey</state>
        <zip>07712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+1-732-695-2555 (111)</phone>
      <email>esher@atlanticallergy.net; csolomon@atlanticallergy.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13854</name>
      <address>
        <city>Verona</city>
        <state>New Jersey</state>
        <zip>07044</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>973-857-1604</phone>
      <email>afost@outlook.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13908</name>
      <address>
        <city>Watertown</city>
        <state>New York</state>
        <zip>13601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>315-681-4192</phone>
      <email>dariusz67@gmail.com;dcstudy@allergistdocs.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13890</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28277</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>980-999-2050</phone>
      <email>ggibson@crcharlotte.com; washe@asthmanc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13863</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>919-881-0309</phone>
      <email>claforce@nccr.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13852</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>405-285-6811</phone>
      <email>jcole@okclinicalresearch.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13879</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>405-945-4495</phone>
      <email>sreyespedpulm@coxinet.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13884</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>405-752-0393</phone>
      <email>mtarpay@mtarpay.com; tarpay@cs.com; tarpay@tarpay.com; tarpay@swbell.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13860</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>918-392-4550</phone>
      <email>iftikhar.hussain@aaicenter.nets</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13861</name>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>541-858-1018</phone>
      <email>ekerwin@allergyasthmaso.com; ekerwin@criresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13874</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>412-833-4051</phone>
      <email>michael.palumbo.1994@owu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13895</name>
      <address>
        <city>Scottdale</city>
        <state>Pennsylvania</state>
        <zip>15683</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>724-220-5281</phone>
      <email>tpluto@frontierclinical.com; tplutoresearch@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13888</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+1-401-681-4960 (202)</phone>
      <email>drz@allergyri.com; drz@aapriresearch.net ; drzaapri@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13871</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>843-820-1036</phone>
      <email>tmurphy@nationalallergyandasthma.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13889</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>843-576-2538</phone>
      <email>thomas.harper@charlestonallergy.com;thomas.harper@aacllp.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13853</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>864-583-1556</phone>
      <email>cfogarty@medresearch.com; charlie@medresearch.com; cfogarty@medresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13898</name>
      <address>
        <city>Baytown</city>
        <state>Texas</state>
        <zip>77521</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>832-606-2053</phone>
      <email>haiderafzal14@gmail.com ; mehkri@primeclinicalresearch.com; inquestclinical@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13867</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>915-544-2557</phone>
      <email>immunman@westernskymed.com; doctorlem@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13902</name>
      <address>
        <city>Killeen</city>
        <state>Texas</state>
        <zip>76542-0969</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>254-690-2800</phone>
      <email>bt99alerg@aol.com;roymwilson@aol.com; drbtmiller@allergycentex.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13846</name>
      <address>
        <city>Live Oak</city>
        <state>Texas</state>
        <zip>78233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>210-646-6978</phone>
      <email>rarastu@msn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13878</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13917</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>210-451-9911</phone>
      <email>txallergydoc@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13845</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13850</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23223</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>804-285-7420</phone>
      <email>kc@crpllc.info; rsc@crpllc.info</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 13915</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>360-733-5733</phone>
      <email>ddelkayam@hinet.org; jselkayam@hinet.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 81041</name>
      <address>
        <city>Kutaisi</city>
        <zip>4600</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+995 431 224 211</phone>
      <email>13.02.66@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 81047</name>
      <address>
        <city>Tbilisi</city>
        <zip>0119</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+995 322 343 353</phone>
      <email>tiniko_gigauri@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 81046</name>
      <address>
        <city>Tbilisi</city>
        <zip>0141</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+995 599 919 699</phone>
      <email>teliatelia54@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 81044</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+995 599 583 017</phone>
      <email>maia.gotua@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 81040</name>
      <address>
        <city>Tbilisi</city>
        <zip>0160</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>ninophirtskhalava@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 81045</name>
      <address>
        <city>Tbilisi</city>
        <zip>0171</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+995 322 146 491</phone>
      <email>l_jorjoliani@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 81042</name>
      <address>
        <city>Tbilisi</city>
        <zip>0179</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+995 322 907 007</phone>
      <email>rusakars@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 81043</name>
      <address>
        <city>Tbilisi</city>
        <zip>0186</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+995 85 995 56 480</phone>
      <email>irineamimino02@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51277</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36 1 334 0790</phone>
      <email>mezei.gyorgyi@med.semmelweis-univ.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51278</name>
      <address>
        <city>Budapest</city>
        <zip>1094</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36 209 548 989 (52821)</phone>
      <email>nagnes56@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51272</name>
      <address>
        <city>Budapest</city>
        <zip>H-1021</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>drmezei6610@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51279</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36-52 511 853</phone>
      <email>i.varkonyi@clintrial.hu;i.varkonyi@clintrial-audit.hu; klinfarm@kenezykorhaz.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51271</name>
      <address>
        <city>Dombovar</city>
        <zip>7200</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36-20-579-5555</phone>
      <email>gyermektudo@gmail.com;laki.istvan@torokbalintkorhaz.hu; gyermektudo@gmail.com; lakiist@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51269</name>
      <address>
        <city>Gyor</city>
        <zip>9023</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36 965 079 13</phone>
      <email>anghelyia@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51274</name>
      <address>
        <city>Kaposvar</city>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36-82-579500</phone>
      <email>sz.gyongyi58@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51270</name>
      <address>
        <city>Miskolc</city>
        <zip>3526</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36-46-515-200</phone>
      <email>barkai.l@axelero.hu;barkai.l@t-online.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51276</name>
      <address>
        <city>Szeged</city>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36-0-625-45342</phone>
      <email>novak.zoltan@med.u-szeged.hu; info@aranyklinika.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 51273</name>
      <address>
        <city>Szigetvar</city>
        <zip>7900</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+36 735 103 64</phone>
      <email>drpappgabor@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50444</name>
      <address>
        <city>Moscow</city>
        <zip>125412</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+7 095 488 4473</phone>
      <email>yulmiz@mail.ru; yulmiz@pautinka.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50446</name>
      <address>
        <city>Perm</city>
        <zip>614066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+7 834 222 81044</phone>
      <email>perminova20062006@yandex.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50445</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>196240</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+7 812 603 3603</phone>
      <email>pte@list.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50443</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>196657</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>laleko@list.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50442</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>191144</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+7 921 748 1596</phone>
      <email>andykkam@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50447</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>192071</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+7 812 360 7504</phone>
      <email>z812@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50441</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>192148</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+781-2913-0423</phone>
      <email>dr.galustyan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50448</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>196191</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+7 921 951 2830</phone>
      <email>tiant@bk.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 50440</name>
      <address>
        <city>Tomsk</city>
        <zip>634050</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+7-382-251-4967</phone>
      <email>sf77@list.ru;olga.sergeevna.fedorova@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58261</name>
      <address>
        <city>Chernivtsi</city>
        <zip>58023</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380-372-575-660</phone>
      <email>bezrukovleonid00@gmail.com;leobezrukov@yandex.ru;kafpedbdmu@yandex.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58262</name>
      <address>
        <city>Dnipropetrovsk</city>
        <zip>49101</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380-563-765-332</phone>
      <email>ilchensv@gmail.com; ilchenko64@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58269</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76014</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380 505 210 370</phone>
      <email>o.urbas@i.ua</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58270</name>
      <address>
        <city>Kharkiv</city>
        <zip>61093</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>doc.polyakov@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58265</name>
      <address>
        <city>Kryvyi Rih</city>
        <zip>50082</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380 667 863 500</phone>
      <email>mokiya@ukr.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58271</name>
      <address>
        <city>Kyiv</city>
        <zip>03115</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>profstepanova@i.ua</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58264</name>
      <address>
        <city>Kyiv</city>
        <zip>04050</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380-444-839-085</phone>
      <email>lapshynbox@ukr.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58268</name>
      <address>
        <city>Kyiv</city>
        <zip>3680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380 504 431 017</phone>
      <email>rechkinalena@list.ru; rechkinaelena@list.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58260</name>
      <address>
        <city>Lviv</city>
        <zip>79059</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380 501 011 137</phone>
      <email>lesya.besh@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58259</name>
      <address>
        <city>Odesa</city>
        <zip>65000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380 503 169 076</phone>
      <email>aryayev@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58272</name>
      <address>
        <city>Odessa</city>
        <zip>65000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>zubarenko_av@ukr.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58263</name>
      <address>
        <city>Vinnytsya</city>
        <zip>21021</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+38 432 511 270</phone>
      <email>alexkatilov@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58267</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>69000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380 667 387 295</phone>
      <email>tanyapulmanolog@gmail.com; tanya_pulmanolog@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Teva Investigational Site 58266</name>
      <address>
        <city>Zaporizhzhya</city>
        <zip>69038</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+380 861 222 49 388</phone>
      <email>snnedelskaya@rambler.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Georgia</country>
    <country>Hungary</country>
    <country>Russian Federation</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Poland</country>
  </removed_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2016</study_first_submitted>
  <study_first_submitted_qc>November 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2016</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluticasone</mesh_term>
    <mesh_term>Salmeterol Xinafoate</mesh_term>
    <mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

